We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Talazoparib in Advanced BRCA-mutated Breast Cancer – No Overall Survival Benefit But Improved Quality of Life

News   Apr 27, 2020 | Original story from MD Anderson Cancer Center

 
Talazoparib in Advanced BRCA-mutated Breast Cancer – No Overall Survival Benefit But Improved Quality of Life Study Finds
 
 
Advertisement
 

RELATED ARTICLES


How Carcinogens Trigger Development of Breast Cancer

News

Scientists have created a detailed map that describes the many ways in which environmental chemicals can trigger cancer.

READ MORE

Converting Autoimmunity Drugs Into Powerful Anticancer Treatments

News

A team from the University of Southampton has discovered a way to transform antibody drugs previously developed to treat autoimmunity into antibodies with powerful anti-cancer activity through a simple molecular “switch”.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE